CERVICAL CANCER PREVENTION IN INDIA: EXAMINING THE CASE FOR LEGAL MANDATES ON VACCINATION
AUTHOR – PRANAV DEEPANKAR KETHINENI, STUDENT AT ALLIANCE SCHOOL OF LAW, ALLIANCE UNIVERSITY, BANGALORE
BEST CITATION – PRANAV DEEPANKAR KETHINENI, CERVICAL CANCER PREVENTION IN INDIA: EXAMINING THE CASE FOR LEGAL MANDATES ON VACCINATION, INDIAN JOURNAL OF LEGAL REVIEW (IJLR), 4 (1) OF 2024, PG. 1470-1487, APIS – 3920 – 0001 & ISSN – 2583-2344.
Abstract
Cervical cancer is one of the growing medical concerns in for women in India. It is the cancer that develops in the cervix of the women which is the entrance to the uterus from the vagina. Various strains of the human papillomavirus, (hereinafter referred as HPV), play a role in causing most cervical cancers. HPV is a common infection that’s passed through sexual contact. When exposed to HPV, the body’s immune system typically prevents the virus from doing harm. In a small percentage of people, however, the virus survives for years. This contributes to the process that causes some cervical cells to become cancer cells. Cervical cancer is the fourth most common cancer in women. In 2018, an estimated 570 000 women were diagnosed with cervical cancer worldwide and about 311 000 women died from the disease. When diagnosed, cervical cancer is one of the most successfully treatable forms of cancer, as long as it is detected early and managed effectively. Cancers diagnosed in late stages can also be controlled with appropriate treatment and palliative care.[1]
[1] https://www.who.int/health-topics/cervical-cancer#tab=tab_2